BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
LEP
,
cell-cell adhesion
,
Ischemia
,
Breast
,
Pharmacogenetics
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Platelet-derived growth factor receptor beta
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cervix
Pericardium
Vagina
Myometrium
Saphenous vein
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bordetellosis
Infection due to Acinetobacter
Aspergillosis
Cryptococcosis
Whipple's disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
aleglitazar
transplatin
Foscarnet
lupeol
2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR21
ADAMTS9
SS18
SERPINB5
Ikzf1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Malignant neoplasms
Drug target sets for approved compounds
OMIM - Kosaki overgrowth syndrome
OMIM - Myeloproliferative disorder
Circulating tumor cells, metastases and primary xenografts expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Platelet-derived growth factor receptor beta
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activ…
A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors
Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib
Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer…
Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ